Search Results - CHEMICAL ANALYSIS

1

COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C (GENOTYPE 1) WITH VARIOUS SEVERITY OF FIBROSIS STAGE

by A. V. Rudakova, D. A. Gusev, A. N. Uskov, I. V. Shestakova, Yu. V. Lobzin
Published 2018-01-01

Subjects: “...budget impact analysis...”

Get full text

Article

2

PROTEASE INHIBITOR NARLAPREVIR IN THERAPY OF HEPATITIS C VIRUS GENOTYPE 1 INFECTION IN TREATMENT-NAÏVE PATIENTS WITHOUT CIRRHOSIS: PHARMACOECONOMIC EVALUATION

by A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin
Published 2017-04-01

“... and simeprevir in combination with peg-INF + RBV.Materials and methods. Analysis of the cost-effectiveness...”

Get full text

Article

3

Cost-effectiveness of narlaprevir in the chronic hepatitis C (genotype 1) therapy in treatment-naïve patients and relapsers

by D. A. Gusev, A. V. Rudakova, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin
Published 2016-11-01

“... of this analysis was to evaluate the cost-effectiveness of narlaprevir and simeprevir in the CHC (genotype 1...”

Get full text

Article

4

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE

by A. V. Rudakova, D. M. Danilenko, D. A. Lioznov, L. S. Karpova, S. M. Kharit, E. V. Mikitenko, A. N. Uskov, A. S. Kolbin, L. N. Konovalova, Yu. V. Lobzin
Published 2019-03-01

“... of epidemiological data on the Russian Federation for a season of 2017/2018.Material and methods. The analysis...”

Get full text

Article

5

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs

by A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, L. S. Namazova-Baranova, O. M. Drapkina, S. N. Avdeev, L. Yu. Drozdova, G. L. Ignatova, I. S. Koroleva, V. A. Korshunov, M. P. Kostinov
Published 2019-12-01

“... infection.Material and methods. Cost-effectiveness analysis was carried out by a modeling method, with a horizon...”

Get full text

Article

6

Cost-effectiveness of quadrivalent human papillomavirus vaccination in adolescent girls

by A. V. Rudakova, S. M. Kharit, A. S. Lisianskaya, A. N. Uskov, Yu. V. Lobzin
Published 2016-11-01

“... assumed that the effect of vaccination remains throughout all life. The analysis is performed for survival...”

Get full text

Article

7

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects

by A. V. Rudakova, S. M. Kharit, Yu. V. Lobzin
Published 2020-01-01

“... of pneumococcal infection.Material and methods. The analysis was carried out by the method of Markov modeling from...”

Get full text

Article

8

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS

by A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, L. S. Namazova-Baranova, S. N. Avdeev, G. L. Ignatova, M. P. Kostinov, I. S. Koroleva, R. V. Polibin, I. V. Fomin
Published 2018-10-01

“... infection.Material and methods. Markov model with 5 and 15 years time horizon was used for the analysis from...”

Get full text

Article

Narrow Search